Biotech Reviews & More

BioSig Technologies, Inc. BSGM

We began tracking many stocks with coronavirus synergies back in the late winter and early spring this year, as the global threat was still in the earlier stages of emergence. Our first alert on BSGM was on April 7th, and the stock would go on to run from under $4 to more than $12,

In the last few weeks, BSGM has finally begun to come down off of those highs, and we are now interesting in tracking it more closely for a potential bottom bounce. We’ll be looking out for the stock to establish support, and possibly make another significant run in coming weeks.

iBio, Inc. IBIO

Speaking of coronavirus related stocks that have done well, IBIO was among those that we have been tracking since word of the pandemic began to spread widely, and we have seen a very nice move from it as well.

Following our most recent mention on March 17th, the stock saw  a low of .76, and to finish off last week it hit a new high of 2.69. That’s a 254% increase, and a perfect example of the kind of impetus that the virus has provided to a lot of these mid-sized biotechs.

Ideanomics, Inc. IDEX

We took notice of an interesting situation with IDEX currently transpiring. Last week, the stock tumbled on word of a possible class action suit currently being investigated. Today, it’s bouncing back in the premarket after the company announced the delivery of more than $3M in Chinese EV orders.

We’ll be interested to track its progress out of the gate as we kick off a fresh trading week today, without any notable earnings reporters on the calendar.

Extended Watchlist: